Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Piper Sandler maintains Glaukos stock at Overweight

EditorAhmed Abdulazez Abdulkadir
Published 05/21/2024, 10:23 AM
GKOS
-

Tuesday, Piper Sandler affirmed its Overweight rating on shares of Glaukos Corporation (NYSE:NYSE:GKOS) with a steady price target of $110.00. The firm's analyst expects minimal impact on Glaukos from the upcoming Medicare coverage decisions on Micro-Invasive Glaucoma Surgery (MIGS).

On Tuesday, the analyst from Piper Sandler commented on the recent developments regarding Medicare Administrative Contractors (MACs) and their consideration of MIGS in their June Open Meetings. The analyst anticipates that the first proposed Local Coverage Determinations (LCDs) will be published either this Thursday or next Thursday, May 30th.

The expectation is that the draft LCDs issued by the MACs will mirror those of the past year and will be released in tandem across all seven MACs. This would provide a clear indication of the Medicare coverage policy for MIGS for the entire country. The analyst has engaged with key stakeholders in the healthcare sector to gauge the potential outcomes of these LCDs.

The analyst's discussions have led to the conclusion that the forthcoming LCDs are likely to be approved without causing significant disruption to Glaukos Corporation or its operations. The focus remains on the expected release of the proposed LCDs, which will offer insights into the likely actions of all the MACs regarding MIGS coverage.

Glaukos Corporation, a medical technology company, continues to be monitored by Piper Sandler as it navigates the regulatory landscape. The firm maintains its positive outlook on the company's stock, with the anticipated Medicare decisions being a key factor in the near term.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.